Jessica Horton
Honorary Associate
Working groups

Background
Jessica completed her PhD, which explored determinants of sustained immunity to malaria, in 2023 under the supervision of Professor James Beeson. Her work investigates immune markers associated with long-lasting antibody-mediated malaria protection and examines vaccine design features and host characteristics which impact vaccine-induced antibody responses.
Prior to commencing her research on malaria at Burnet Institute in 2019, Jessica studied viral triggers of type 1 diabetes as an Honours student and Research Assistant at the Prince of Wales Hospital and University of NSW.
Qualifications
- 2023: Doctor of Philosophy, University if Melbourne
- 2016: Bachelor of Advanced Science (Honours), University of NSW
Positions
- 2023: Research Assistant, Burnet Institute
- 2019–2023: PhD student, Burnet Institute
- 2017–2018: Research Assistant, University of NSW
Awards
- 2020: Australian Centre of Research Excellence in Malaria Elimination (ACREME) Travel Award
- 2019: University of Melbourne Research Training Program Scholarship
- 2019: Three-minute thesis People’s Choice Award, Burnet Student Symposium
- 2016: School of Biotechnology and Biomolecular Sciences Honours Scholarship, University of NSW
- 2015: University of NSW Faculty of Science Dean’s List
Burnet publications
View 2 moreDeclining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate
The Journal of Infectious Diseases
Kristina E. M. Persson et al
Multi-functional antibody profiling for malaria vaccine development and evaluation
Expert Review of Vaccines
D. Herbert Opi et al
Higher abundance of enterovirus A species in the gut of children with islet autoimmunity
Scientific Reports
Jessica L. Horton
Current projects
Malaria Synergy Program
The program brings together experts to achieve the goals of malaria elimination in the Asia-Pacific region and globally.
MASTER-MAP: modern acceleration strategies for eradication of malaria in the Asia Pacific
We're developing novel solutions and high-quality evidence to inform policies and practices that address the major barriers in malaria elimination.